0001735276-24-000033.txt : 20240328 0001735276-24-000033.hdr.sgml : 20240328 20240328161717 ACCESSION NUMBER: 0001735276-24-000033 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240320 FILED AS OF DATE: 20240328 DATE AS OF CHANGE: 20240328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fitzgerald Kevin Joseph CENTRAL INDEX KEY: 0001886431 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36407 FILM NUMBER: 24799188 MAIL ADDRESS: STREET 1: C/O OVID THERAPEUTICS INC. STREET 2: 1460 BROADWAY, SUITE 15044 CITY: NEW YORK STATE: NY ZIP: 10036 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALNYLAM PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001178670 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 770602661 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: (617) 551-8200 MAIL ADDRESS: STREET 1: 675 WEST KENDALL STREET STREET 2: HENRI A. TERMEER SQUARE CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: ALNYLAM PHARMACEUTICALS INC DATE OF NAME CHANGE: 20020724 3 1 edgardoc.xml PRIMARY DOCUMENT X0206 3 2024-03-20 0 0001178670 ALNYLAM PHARMACEUTICALS, INC. ALNY 0001886431 Fitzgerald Kevin Joseph 675 WEST KENDALL STREET HENRI A. TERMEER SQUARE CAMBRIDGE MA 02142 0 1 0 0 CSO & EVP, Head of Research Common Stock 12881 D Common Stock 537 I by Managed Account Performance Stock Option 2017 (right to buy) 119.13 2021-02-11 2028-03-01 Common Stock 9000 D Stock Option (right to buy) 85.0 2029-02-28 Common Stock 16250 D Stock Option (right to buy) 97.72 2025-12-07 Common Stock 6667 D Stock Option (right to buy) 118.05 2030-02-26 Common Stock 14580 D Stock Option (right to buy) 119.13 2028-03-01 Common Stock 9000 D Stock Option (right to buy) 147.47 2032-02-23 Common Stock 20382 D Stock Option (right to buy) 151.59 2031-02-24 Common Stock 15692 D Stock Option (right to buy) 152.61 2034-03-01 Common Stock 9279 D Stock Option (right to buy) 190.01 2033-02-27 Common Stock 10352 D Reflects shares of ALNY common stock acquired by the Reporting Person under the issuer 401(k) plan as a result of the issuer 401(k) matching contribution program. The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter until the fourth anniversary of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. The stock option vests as to 25% of the shares on the first anniversary of the grant date and the remaining shares vest in equal installments at the end of each successive three-month period thereafter over the following thirty-three (33) months of the grant date, subject to the Reporting Persons continuous service with the Issuer as of each such vesting date. Exhibit List: Exhibit 24 - Power of Attorney By: Brett Budzinski, Attorney-in-Fact For: Kevin Fitzgerald 2024-03-28